Market Overview:
The global icotinib market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising prevalence of cancer, increasing demand for targeted therapies, and growing investments by pharmaceutical companies in R&D for new drugs. Based on type, the global icotinib market is segmented into 250mg and 125mg. The 250mg segment is expected to account for a larger share of the market than the 125mg segment during the forecast period. This can be attributed to its higher efficacy compared with other dosages. Based on application, the global icotinib market is divided into hospital and drug store segments.
Product Definition:
Icotinib is a novel, small molecule tyrosine kinase inhibitor that blocks the activity of mutants of EGFR responsible for T790M resistance in non-small cell lung cancer (NSCLC) cells.
250mg:
250mg is a medicine used for the treatment of chronic myeloid leukemia. It is also known as Icotinib and has to be taken in combination with another medicine called Glivec. The other half of the 250mg tablet consists of Glivec which works by increasing levels of “glucose-6-phosphate dehydrogenase” an enzyme that helps cells use sugar (glucose) and produce energy.
125mg:
Icotinib is a generic name for the targeted drug, which is used in the treatment of chronic myeloid leukemia. 125mg capsules are used to treat this blood cancer. Icotinib’s mechanism of action involves inhibiting the tyrosine kinase activity by binding to and occupying its site on the cell membrane; it does not affect other proteins or enzymes involved in cellular processes.
Application Insights:
Drug store was the largest application segment in 2017 and accounted for over 60% of the total revenue. Drug stores are available in every city, town and rural area of the globe. High availability of internet cafĩs has led to a significant increase in iotib use as a recreational drug among young adults. Growing awareness regarding health issues coupled with rising usage rates is expected to drive demand for iotinib over the forecast period.
Hospital application segment is anticipated to witness growth at CAGR around 7% from 2018 to 2030 owing to high usage rates as an anti-cancer agent across various regions including North America, Europe and Asia Pacific countries such as China, Japan etc., Moreover, increasing R&D activities by major players coupled with new product launch by them is likely to propel market growth over the coming years.
Regional Analysis:
North America was the largest regional market in 2017 owing to high awareness levels regarding cancer treatment options and increasing number of FDA approvals. The region is expected to maintain its dominance during the forecast period due to presence of key manufacturers coupled with high healthcare expenditure. Asia Pacific is estimated to be fastest-growing regional market over the forecast years due to rising demand for cost-effective drugs, improving healthcare infrastructure, and growing target population base. Moreover, availability of generic iotinib products in countries such as India and China will drive growth further.
Key players operating in global arena include Actavis plc., Pfizer Inc., Merck & Co., Inc.
Growth Factors:
- Increasing incidence of lung cancer: The incidence of lung cancer is increasing globally due to the increase in the number of smokers and exposure to environmental pollutants. This is expected to drive the demand for icotinib, as it is a targeted therapy for lung cancer.
- Rising awareness about icotinib: There is a growing awareness among physicians and patients about the benefits of icotinib over traditional chemotherapy regimens for treating various types of cancers. This is likely to boost demand for icotinib in the coming years.
- Availability of reimbursement policies: A large number of countries have introduced reimbursement policies for icotinib, which has helped improve patient access to this drug. This is likely to spur growth in the global market for icotinib during the forecast period.
- Growing investment in oncology research: The pharmaceutical industry has been investing heavily in oncology research over the past few years, with a focus on developing novel therapies such as targeted drugs and immunotherapies. This is expected to lead to increased adoption of icotinib worldwide and drive market growth during the forecast period . 5
Scope Of The Report
Report Attributes
Report Details
Report Title
Icotinib Market Research Report
By Type
250mg, 125mg
By Application
Hospital, Drugs Store
By Companies
Bette Pharma, Bette Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
146
Number of Tables & Figures
103
Customization Available
Yes, the report can be customized as per your need.
Global Icotinib Market Report Segments:
The global Icotinib market is segmented on the basis of:
Types
250mg, 125mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drugs Store
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bette Pharma
- Bette Pharma
Highlights of The Icotinib Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 250mg
- 125mg
- By Application:
- Hospital
- Drugs Store
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Icotinib Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Icotinib is a drug that inhibits the growth of cancer cells. It is approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with advanced non-small cell lung cancer (NSCLC). Icotinib is also being studied as a potential treatment for other types of cancer, including pancreatic, ovarian, and head and neck cancers.
Some of the major companies in the icotinib market are Bette Pharma, Bette Pharma.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Icotinib Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Icotinib Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Icotinib Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Icotinib Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Icotinib Market Size & Forecast, 2018-2028
4.5.1 Icotinib Market Size and Y-o-Y Growth
4.5.2 Icotinib Market Absolute $ Opportunity
Chapter 5 Global Icotinib Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Icotinib Market Size Forecast by Type
5.2.1 250mg
5.2.2 125mg
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Icotinib Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Icotinib Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drugs Store
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Icotinib Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Icotinib Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Icotinib Analysis and Forecast
9.1 Introduction
9.2 North America Icotinib Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Icotinib Market Size Forecast by Type
9.6.1 250mg
9.6.2 125mg
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Icotinib Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drugs Store
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Icotinib Analysis and Forecast
10.1 Introduction
10.2 Europe Icotinib Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Icotinib Market Size Forecast by Type
10.6.1 250mg
10.6.2 125mg
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Icotinib Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drugs Store
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Icotinib Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Icotinib Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Icotinib Market Size Forecast by Type
11.6.1 250mg
11.6.2 125mg
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Icotinib Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drugs Store
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Icotinib Analysis and Forecast
12.1 Introduction
12.2 Latin America Icotinib Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Icotinib Market Size Forecast by Type
12.6.1 250mg
12.6.2 125mg
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Icotinib Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drugs Store
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Icotinib Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Icotinib Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Icotinib Market Size Forecast by Type
13.6.1 250mg
13.6.2 125mg
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Icotinib Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drugs Store
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Icotinib Market: Competitive Dashboard
14.2 Global Icotinib Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Bette Pharma
14.3.2 Bette Pharma
